NO820073L - PROCEDURE FOR THE PREPARATION OF 4-AMINOBUTYRAMIDES - Google Patents

PROCEDURE FOR THE PREPARATION OF 4-AMINOBUTYRAMIDES

Info

Publication number
NO820073L
NO820073L NO820073A NO820073A NO820073L NO 820073 L NO820073 L NO 820073L NO 820073 A NO820073 A NO 820073A NO 820073 A NO820073 A NO 820073A NO 820073 L NO820073 L NO 820073L
Authority
NO
Norway
Prior art keywords
stated
nitro
butyramide
preparation
carried out
Prior art date
Application number
NO820073A
Other languages
Norwegian (no)
Inventor
Jacques Gosteli
Michel Mangane
Guy Rossey
Alexander Wick
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO820073L publication Critical patent/NO820073L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Abstract

1. A process for the preparation of 4-aminobutyramide characterized in that 4-nitrobutyramide is reduced by hydrogenation in the presence of a catalyst.

Description

Foreliggende oppfinnelse vedrører en fremgangsmåte for fremstilling av 4-butyramid og det særegne ved fremgangsmåten i' henhold til oppfinnelsen er at man reduserer 4-nitrobutyramid. The present invention relates to a method for the production of 4-butyramide and the distinctive feature of the method according to the invention is that 4-nitrobutyramide is reduced.

Disse og andre trekk ved oppfinnelsen fremgår av patent-kravene. These and other features of the invention appear in the patent claims.

I litteraturen er tidligere beskrevet forskjellige metoder for fremstilling av 4-amino-butyramid eller såkalt "gabamid", se spesielt artikkelen i Angew. Chem. Int. Ed. 19 (1980), side 627 som beskriver selektiv hydrogenering av 3-cyano-propionamid i nærvær av hydro-genklorid. Various methods for the production of 4-amino-butyramide or so-called "gabamid" have previously been described in the literature, see in particular the article in Angew. Chem. Int Ed. 19 (1980), page 627 which describes the selective hydrogenation of 3-cyano-propionamide in the presence of hydrogen chloride.

Den foreliggende oppfinnelse vedrører en overraskende enkel og lønnsom fremgangsmåte som fører til gabamid med meget godt utbytte og fremgangsmåten i henhold til oppfinnelsen kan representeres ved hjelp av følgende reak-sjonsskj erna The present invention relates to a surprisingly simple and profitable method which leads to gabamide with a very good yield and the method according to the invention can be represented by means of the following reaction core

Utgangsforbindelsen, nemlig alkyl-4-nitro-butanoat og mer spesielt metyl-4-nitrobutanoat, er beskrevet i litteraturen, se J. Org- Chem, 1962,! 1609. The starting compound, namely alkyl-4-nitro-butanoate and more particularly methyl-4-nitrobutanoate, is described in the literature, see J. Org-Chem, 1962,! 1609.

Det første trinn i fremgangsmåten består i å omdanne alkyl-4-nitro-butanoatet til 4-nitro-butyramid ved hjelp av passende midler for omdannelse av en ester til et amid, f.eks. ved aminolyse, spesielt i nærvær av ammoniakk og ammoniumklorid. 4-nitrobutyramid er kjent og er blitt fremstilt ved hjelp av en forskjellig metode likeledes beskrevet i J. Org. Chem., 1962, 1609. The first step in the process consists in converting the alkyl-4-nitro-butanoate to 4-nitro-butyramide by means of suitable means for converting an ester to an amide, e.g. by aminolysis, especially in the presence of ammonia and ammonium chloride. 4-nitrobutyramide is known and has been prepared using a different method likewise described in J. Org. Chem., 1962, 1609.

Reduksjonen av 4-nitro-butyramid til 4-amino-butyramid gjennomføres ved hjelp av hvilke som helst passende midler for reduksjon av nitrogruppen og kan spesielt gjennomføres ved hydrogenering i nærvær av en kata- The reduction of 4-nitro-butyramide to 4-amino-butyramide is carried out by any suitable means for the reduction of the nitro group and can in particular be carried out by hydrogenation in the presence of a cata-

lysator og en syre, under et trykk på fra 1 til 10 bar og en temperatur fra 0 til 50°C. lysator and an acid, under a pressure of from 1 to 10 bar and a temperature of from 0 to 50°C.

Hydrogeneringskatalysatorene er f.eks. platinaoksyd Pt02eller Raney-nikkel. The hydrogenation catalysts are e.g. platinum oxide PtO 2 or Raney nickel.

Den syre som foretrekkes er saltsyre. The preferred acid is hydrochloric acid.

Følgende eksempler illustrerer oppfinnelsen. The following examples illustrate the invention.

EKSEMPEL 1 EXAMPLE 1

A. 4-nitro-butyramid A. 4-nitro-butyramide

I en 500 ml erlenmeyer-kolbe innføres 15 g (0,102 m) metyl-4-nitro-butanoat i 60 ml ammoniakk (densitet 0,92) og 1,5 g (0,03 m) ammoniumklorid. Det omrøres magnetisk over natten ved romtemperaturen. Oppløsningen inndampes under vakuum ved 45 til 50°C. Resten opptas i 200 ml etylacetat og oppløsningen filtreres for fjernelse av salter. Litt aktivkarbon tilsettes, og oppløsningen filtreres og inndampes til 1/3 av det initiale volum. Produktet krystalli,-serer i form av hvite krystaller. Into a 500 ml Erlenmeyer flask, introduce 15 g (0.102 m) of methyl 4-nitro-butanoate in 60 ml of ammonia (density 0.92) and 1.5 g (0.03 m) of ammonium chloride. It is magnetically stirred overnight at room temperature. The solution is evaporated under vacuum at 45 to 50°C. The residue is taken up in 200 ml of ethyl acetate and the solution is filtered to remove salts. A little activated carbon is added, and the solution is filtered and evaporated to 1/3 of the initial volume. The product crystallizes in the form of white crystals.

Smeltepunkt = 89°C (Kofler)/88-89°C (Tottoli: 1°C). Melting point = 89°C (Kofler)/88-89°C (Tottoli: 1°C).

Utbytte: 13,47 g (100%). Yield: 13.47 g (100%).

Spektra IR og RMN bekreftes. IR and NMR spectra are confirmed.

B. 4- amino- butyramid ( hydroklorid) B. 4-amino-butyramide (hydrochloride)

I en Parr-bombe innføres 0,25 g (1,9 m mol) 4-nitrobutyr- In a Parr bomb, 0.25 g (1.9 m mol) of 4-nitrobutyr-

amid, 20 ml metanol, 5 ml 1 N saltsyre og 0,02 Pt02. Det omrøres i 2 timer ved 20°C under hydrogen (4 bar) platina-oksydet frafiltreres og oppløsningen inndampes og resten amide, 20 mL methanol, 5 mL 1 N hydrochloric acid, and 0.02 PtO 2 . It is stirred for 2 hours at 20°C under hydrogen (4 bar), the platinum oxide is filtered off and the solution is evaporated and the residue

opptas i 5 ml etanol. Oppløsningen tilsettes så 20 ml etylacetat og det krystalliserte produkt frafiltreres og tørkes. taken up in 5 ml of ethanol. The solution is then added with 20 ml of ethyl acetate and the crystallized product is filtered off and dried.

Smeltepunkt = 139 - 140°C (Kofler); 138°C (Tottoli: l°C/min.). Melting point = 139 - 140°C (Kofler); 138°C (Tottoli: 1°C/min.).

Utbytte: 0,218 g (98%) Yield: 0.218 g (98%)

Spektra IR og RMN er identiske med en autentisk produkt-prøve. The IR and RMN spectra are identical to an authentic product sample.

Fremgangsmåten i henhold til oppfinnelsen tillater at The method according to the invention allows that

man med meget godt utbytte og på økonomisk måte kan fremstille gabamid som er et produkt kjent for sine psykotrope egenskaper og utgangsmaterial for syntese som fører til benzyliden-derivater med verdifulle farmakologiske egenskaper. gabamide, which is a product known for its psychotropic properties and starting material for synthesis that leads to benzylidene derivatives with valuable pharmacological properties, can be produced with very good yield and economically.

Claims (8)

1. Fremgangsmåte for fremstilling av 4-amino-butyramid,karakterisert vedat man reduserer 4-nitrobutyramid.1. Process for the production of 4-amino-butyramide, characterized by reducing 4-nitrobutyramide. 2. Fremgangsmåte som angitt i krav 1,karakterisert vedat reduksjonen foretas som hydrogenering i nærvær av en katalysator.2. Method as stated in claim 1, characterized in that the reduction is carried out as hydrogenation in the presence of a catalyst. 3. Fremgangsmåte som angitt i krav 2,karakterisert vedat det som katalysator anvendes platinaoksyd eller Raney-nikkel.3. Method as stated in claim 2, characterized in that platinum oxide or Raney nickel is used as catalyst. 4. Fremgangsmåte som angitt i krav 3,karakterisert vedat hydrogeneringen gjennomføres i nærvær av platina-oksyd og en syre.4. Method as stated in claim 3, characterized in that the hydrogenation is carried out in the presence of platinum oxide and an acid. 5. Fremgangsmåte som angitt i krav 4,karakterisert vedat det som syre anvendes saltsyre.5. Method as stated in claim 4, characterized in that hydrochloric acid is used as acid. 6. Fremgangsmåte som angitt i krav 1,karakterisert vedat 4-nitrobutyramid fremstilles fra et alkyl-4-nitro-butanoat.6. Method as stated in claim 1, characterized in that 4-nitrobutyramide is produced from an alkyl-4-nitro-butanoate. 7. Fremgangsmåte som angitt i krav 6,karakterisert vedat alkyl-4-nitro-butanoatet omdannes til 4-nitro-butyramid ved hjelp av aminolyse.7. Method as stated in claim 6, characterized in that the alkyl-4-nitro-butanoate is converted to 4-nitro-butyramide by means of aminolysis. 8. Fremgangsmåte som angitt i krav 7,karakterisert vedat aminolysen gjennomføres ved hjelp av ammoniakk og ammoniumklorid.8. Method as stated in claim 7, characterized in that the aminolysis is carried out using ammonia and ammonium chloride.
NO820073A 1981-01-13 1982-01-12 PROCEDURE FOR THE PREPARATION OF 4-AMINOBUTYRAMIDES NO820073L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8100440A FR2497797A1 (en) 1981-01-13 1981-01-13 PROCESS FOR THE PREPARATION OF AMINO-4 BUTYRAMIDE

Publications (1)

Publication Number Publication Date
NO820073L true NO820073L (en) 1982-07-14

Family

ID=9254051

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820073A NO820073L (en) 1981-01-13 1982-01-12 PROCEDURE FOR THE PREPARATION OF 4-AMINOBUTYRAMIDES

Country Status (16)

Country Link
EP (1) EP0056343B1 (en)
JP (1) JPS57139046A (en)
AT (1) ATE6933T1 (en)
AU (1) AU7945582A (en)
DE (1) DE3260086D1 (en)
DK (1) DK10082A (en)
ES (1) ES508656A0 (en)
FI (1) FI820092L (en)
FR (1) FR2497797A1 (en)
GR (1) GR75180B (en)
IE (1) IE52513B1 (en)
IL (1) IL64760A0 (en)
NO (1) NO820073L (en)
NZ (1) NZ199468A (en)
PT (1) PT74274A (en)
ZA (1) ZA82185B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012006839A2 (en) * 2009-10-06 2016-06-07 Bayer Cropscience Ag Method for the production of 2,2-difluoroethylamine by hydrogenation of 1-1-difluor-2-nitroethane

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1225419A (en) * 1958-07-29 1960-06-30 Montedison Spa Process for the preparation of omega-aminocaprylic acid amide and products obtained by this process
DE2316459C2 (en) * 1973-04-03 1982-06-24 Hoechst Ag, 6000 Frankfurt Process for the preparation of 1-nitrobenzene-2-carboxylic acid alkyl ester-5-carboxamides
DE2319360A1 (en) * 1973-04-17 1974-11-07 Basf Ag PROCESS FOR THE PRODUCTION OF EPSILONAMINOCAPRONIC ACID AMIDE

Also Published As

Publication number Publication date
AU7945582A (en) 1982-07-22
ZA82185B (en) 1983-01-26
NZ199468A (en) 1984-05-31
JPS57139046A (en) 1982-08-27
ATE6933T1 (en) 1984-04-15
FR2497797A1 (en) 1982-07-16
IE820049L (en) 1982-07-13
ES8502080A1 (en) 1984-12-01
FR2497797B1 (en) 1983-12-23
EP0056343A1 (en) 1982-07-21
FI820092L (en) 1982-07-14
DE3260086D1 (en) 1984-05-10
GR75180B (en) 1984-07-13
IE52513B1 (en) 1987-11-25
EP0056343B1 (en) 1984-04-04
PT74274A (en) 1982-02-01
DK10082A (en) 1982-07-14
ES508656A0 (en) 1984-12-01
IL64760A0 (en) 1982-03-31

Similar Documents

Publication Publication Date Title
RU2405787C2 (en) Method for synthesis of 4beta-amino-4'-demethyl-4-desoxypodophyllotoxin
WO1999000362A1 (en) Synthesis of aminocarbonyl substituted lactams
EP0347818B1 (en) Process for preparing 3-pyrrolidinol
KR100956490B1 (en) A process for preparing pseudo-aminosugars using new dehalogenation reagent
NO820073L (en) PROCEDURE FOR THE PREPARATION OF 4-AMINOBUTYRAMIDES
KR100278348B1 (en) Process for preparing aqueous nigotinaldehyde
Beyerman et al. Stereospecific synthesis and optical resolution of 5‐hydroxypipecolic acid
KR100303593B1 (en) Process for the preparation of pyridyl methyl aminotriazinone
KR20020067575A (en) Method for producing N-methyl-N'-nitroguanidine
CA1340193C (en) Process for preparing dihydropyridine derivatives
DE69934712T2 (en) METHOD OF PREPARING N-NEOHEXYL- (A) -ASPARTYL-L-PHENYL ALANINE METHYL ESTERS FROM INTERMEDIATE COMPOUNDS CONTAINING IMIDAZOLIDIN-4-ON
GB2041932A (en) Method for producing 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piper-azinyl) quinazoline hydrochloride
CN114105848B (en) Preparation method of cis-D-hydroxyproline derivative
JPH01190655A (en) N, omega trifluoroacetylation of saturated aliphatic alpha, omega-diaminomonocarboxylic acid
IE851273L (en) Process for preparing rimantadine.
NO324601B1 (en) Process for the preparation of distamycin derivatives and intermediates for use therein.
JPH0597826A (en) Production of 6-amino-7-fluoro-2h-1,4-benzoxazin3(4h)-one
GB2170806A (en) N-(b-mercapto-iso-butyryl)proline, derivatives and a process for their preparation
JP2714396B2 (en) Preparation of pyrrolidine derivatives
JP3041444B2 (en) Method for producing carbazic acid derivative
JPS5832861A (en) 2-substituted amino-4-chloro-thiophenol derivative and its preparation
JPS5855459A (en) Preparation of optically active tryptophan derivative
SU332627A1 (en)
NO179324B (en) Process for the preparation of 5-chloroxindole
CN112094247A (en) Cephalosporin drug intermediate and synthesis method thereof